CALIXAR certifies that your expression system conforms to your drug discovery project when targeting membrane proteins. We can also provide options in the case that your expression fails qualification steps.
CALIXAR has been successfully supporting membrane protein research from our customers for over a decade now. Membrane proteins are one of the most challenging drug targets to produce and purify, because of their strong bond with the lipid bilayer, involving electrostaticity, hydrogen, and other types of binding. These proteins can vary in size from small peptides to large membrane-bound enzymes, with many different biochemical properties that often require optimization before high scale expression.
Membrane proteins play key roles in life processes, which is why they are attractive targets for drug discovery projects. They can be membrane-bound receptors such as GPCRs, ion channels, transporters, enzymes, or others. Membrane protein-based pharmaceuticals represent more than 60% of all commercialized pharmaceutical drugs including anti-infectives (antibiotics, antivirals,…), cardiovascular therapies (lipid regulators, anticoagulants,…), neurological medicines (pain killers, antiepileptics), and more.
CALIXAR’s membrane protein services include membrane protein expression, solubilization, purification & characterization among others. We also offer membrane protein services to support customers in early research phases (up to Pre-Clinical), or for companies who may be looking for a contract research organization (CRO), or Membrane Protein service providers to supplement their own Membrane Protein capabilities.
View our membrane protein services below :